Devices & Diagnostics Medtronic CEO expects to submit renal denervation data to FDA this year, overcoming previous failures By Arundhati Parmar
Devices & Diagnostics, Pharma, Startups Michigan medtech company raises $77M for renal denervation solution to hypertension By Kevin Truong
Devices & Diagnostics Still in the renal denervation space? Startups, consider adaptive trial design, CRO says By Lindsey Alexander
Devices & Diagnostics Two top medical device companies announce promising renal denervation tech results By Lindsey Alexander
Devices & Diagnostics BSX’s $300M acquisition of Vessix Vascular shows continued consolidation in renal denervation By Arundhati Parmar
Channel St. Jude Medical’s renal denervation system effective in lowering blood pressure By Arundhati Parmar
Devices & Diagnostics Medtronic’s Symplicity system not enough to keep lead in renal denervation By Arundhati Parmar
Devices & Diagnostics ReCor Medical enrolls first patients for study to test device designed to treat hypertension By Nicole Oran
BioPharma A VC’s take on the $1.3 billion acquisition of CinCor Pharma by AstraZeneca By Arundhati Parmar
Devices & Diagnostics Skeptical of future performance, spooked by recent misses, Needham analyst downgrades Medtronic’s stock By Arundhati Parmar
Devices & Diagnostics Key takeaways from Medtronic CEO’s presentation at virtual JPM conference By Arundhati Parmar
Devices & Diagnostics, Startups Can you kill two birds (slow heart beat and hypertension) with one stone (pacemaker)? By Arundhati Parmar
Devices & Diagnostics Device startup raises $2M to build iPod-sized wearable that uses ultrasound for pain By Stephanie Baum
